Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yang JW et al. – Nafamostat mesylate has a similar profile of anti–coagulative activity to heparin. It is assumed, however, that nafamostat has an affirmative effect on the recovery of damaged sites following the onset of cerebral hemorrhage. It is an anti–coagulant that can be safely used for hemodialysis following the onset of cerebral hemorrhage.

   

Related Articles

Psoas abscess in hemodialysis patients
International Urology and Nephrology, 10/06/09    Relevance Score: 90%

Improved Nutrition After Conversion to Nocturnal Home Hemodialysis
Journal of Renal Nutrition, 10/14/09    Relevance Score: 89%

Permanent Hearing Loss With Iopamidol Following Aortic Angiography in a Hemodialysis Patient: A Case Report and Review of the Literature
American Journal of Kidney Diseases, 10/28/09    Relevance Score: 87%

Prevalence and Cardiovascular Features of Japanese Hemodialysis Patients with Fabry Disease
American Journal of Nephrology, 10/16/09    Relevance Score: 87%

Revised Dyadic Adjustment Scale as a Reliable Tool for Assessment of Quality of Marital Relationship in Patients on Long-Term Hemodialysis
Iranian Journal of Kidney Diseases, 10/13/09    Relevance Score: 87%

Today in Nephrology/Urology...keeping you current

Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study
Cardiovascular Diabetology, 12/10/09

Analysis of recessive CD2AP and ACTN4 mutations in steroid-resistant nephrotic syndrome
Pediatric Nephrology, 12/10/09

IgA nephropathy presenting with renal failure and pulmonary hemorrhage
Pediatric Nephrology, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address